Cutaneous fungal infections of the foot
Pro Research Analysisby 
Searched over 200M research papers
Prevalence and Epidemiology of Cutaneous Fungal Infections of the Foot
Cutaneous fungal infections of the foot, commonly known as tinea pedis or athlete’s foot, are among the most frequent dermatological conditions affecting the feet worldwide. It is estimated that up to 70% of people will experience a fungal foot infection at least once in their lifetime, with a prevalence of about 15% in the general population in some regions 346. These infections are more common in adults, particularly men, and are less frequent in women and children 34. The most commonly affected sites in adults are the feet and nails, while in children, the scalp and nails are more often involved .
Common Causative Agents and Clinical Manifestations
The primary pathogens responsible for cutaneous fungal infections of the foot are dermatophytes, especially species of Trichophyton (such as T. rubrum and T. mentagrophytes), Epidermophyton floccosum, and, less commonly, T. tonsurans 379. Non-dermatophyte fungi, including Candida and Aspergillus species, can also cause infections, particularly in immunocompromised individuals or those with underlying conditions like diabetes 25710. Clinical presentations vary and may include itching, flaking, fissuring, and, in some cases, cystic or plaque-like lesions 34510. Nail involvement (onychomycosis) is characterized by thickening and discoloration of the toenails 14.
Risk Factors and Special Populations
Several risk factors increase susceptibility to foot fungal infections. These include frequent use of communal swimming pools, industrial work environments, and underlying health conditions such as diabetes mellitus 248. Diabetic patients are particularly at risk, with higher rates of both skin and nail fungal infections, especially in the presence of foot ulcers. Poorly controlled diabetes is associated with increased infection rates and a higher risk of complications, including amputation 28.
Diagnostic Approaches
Diagnosis of cutaneous fungal infections relies on clinical examination, direct microscopic evaluation, and fungal cultures. Advanced diagnostic tools, such as MALDI-TOF mass spectrometry and PCR, are increasingly used for accurate identification of the causative organisms 379. Accurate diagnosis is essential for effective management and to minimize the risk of antifungal resistance .
Treatment Strategies and Antifungal Resistance
Treatment options for fungal foot infections include topical and oral antifungal agents. Topical treatments are typically used for mild cases, while oral therapies are reserved for chronic or refractory infections. Among oral agents, terbinafine has been shown to be more effective than griseofulvin, and both terbinafine and itraconazole are more effective than placebo . However, resistance to commonly used antifungals, such as fluconazole and itraconazole, is an increasing concern, particularly among Candida and Aspergillus species isolated from diabetic foot ulcers 278. Non-dermatophyte infections are especially challenging to treat due to higher rates of treatment failure .
Uncommon and Opportunistic Infections
While dermatophytes are the most common cause, rare and opportunistic fungal infections can occur, especially in immunosuppressed individuals. Cases of cutaneous aspergillosis and phaeohyphomycosis caused by unusual fungi like Phialemoniopsis limonesiae have been reported, often presenting as atypical lesions and requiring specialized diagnostic and therapeutic approaches 510.
Conclusion
Cutaneous fungal infections of the foot are common and can present with a variety of clinical manifestations. Dermatophytes are the primary causative agents, but non-dermatophyte and opportunistic fungi are increasingly recognized, especially in high-risk populations such as diabetics and immunosuppressed patients. Accurate diagnosis and appropriate treatment are essential, particularly in the context of rising antifungal resistance. Ongoing surveillance and targeted prevention strategies are needed to address changing epidemiological trends and improve patient outcomes 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic